|
National Stock Number(NSN): 6505-01-265-1327 (6505012651327, 012651327)
| NIIN: |
01-265-1327 |
Item Name: |
QUININE SULFATE CAPSULES |
INC: |
31177
|
| FSC: |
6505
|
Assignment Date: |
Oct-10-1987 |
CRIT: |
X |
IIG: |
31177 |
| ISC: |
5 |
Date Standardized: |
Oct-10-1987 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
A |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
3004.90.9225 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
3808 |
65350
|
MEDICAL TECHNOLOGIES SYSTEM INC VANGARD LABS DIV |
H |
3 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00615-0323-13 |
65350
|
MEDICAL TECHNOLOGIES SYSTEM INC VANGARD LABS DIV |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DN |
S9M |
Y |
|
Q |
U |
1 |
N |
$9.51 |
PG |
|
9L----- |
May-01-1993 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
325.000 MILLIGRAMS QUININE SULFATE ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
INDIVIDUALLY SEALED |
| CQCT |
PRIMARY CONTAINER TYPE |
STRIP |
| CQLS |
CAPSULE CONTENT FORM |
ANY ACCEPTABLE |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
100.000 |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| SUPP |
SUPPLEMENTARY FEATURES |
MEDSEP ITEM FOR DOD,VANGARD LABS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|